Evidence map›Paper›PMID 31671877›Full record

ArticleMedicina (Kaunas, Lithuania)2019

Dose Intensive Rituximab and High-Dose Methylprednisolone in Elderly or Unfit Patients with Relapsed Chronic Lymphocytic Leukemia.

Regina Pileckyte, Vilma Valceckiene, Mindaugas Stoskus, Reda Matuzeviciene, Jurgita Sejoniene, Tadas Zvirblis, Laimonas Griskevicius

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01576588 (Study of Rituximab in Addition to Glucocorticoid in Pretreated Elderly or Unfit Patients With Chronic B Lymphocytic Leukemia), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01576588 phase2completednot on this map

Study of Rituximab in Addition to Glucocorticoid in Pretreated Elderly or Unfit Patients With Chronic B Lymphocytic Leukemia

TypeinterventionalSponsorProf. Dr. Med. Laimonas GriskeviciusRan2011 to 2019Enrolled25ConditionsB-Cell Chronic Lymphocytic LeukemiaArmsRituximab, Glucocorticoid
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Regina PileckyteHematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania. regina.pileckyte@santa.lt.
Vilma ValceckieneHematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania. vilma.valceckiene@santa.lt.
Mindaugas StoskusHematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania. mindaugas.stoskus@santa.lt.
Reda MatuzevicieneLaboratory Diagnostics Centre, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania. reda.matuzeviciene@santa.lt.
Jurgita SejonieneRadiology and Nuclear Medicine Center, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania. jurgita.sejoniene@santa.lt.
Tadas ZvirblisHematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania. tadas.zvirblis@gmail.com.
Laimonas GriskeviciusHematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, 08661 Vilnius, Lithuania. jurgita.sejoniene@santa.lt.
Vilnius University · LT

Funding

Roche study drug Rituximab was provided
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAged, 80 and overAntineoplastic AgentsFemaleHumansLeukemia, Lymphocytic, Chronic, B-CellMaleMethylprednisoloneProspective StudiesRituximabAntineoplastic AgentsMethylprednisoloneRituximabchronic lymphocytic leukemiaelderlyhigh-dose methylprednisolonerituximab

Identifiers

PMID31671877
PMCPMC6915691
OpenAlexW2982337378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.